Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
OncoCyte: Q3 Earnings Snapshot AP - Tue Nov 12, 3:50PM CST

OncoCyte: Q3 Earnings Snapshot

OCX : 2.65 (-3.53%)
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025 GlobeNewswire - Tue Nov 12, 3:05PM CST

OCX : 2.65 (-3.53%)
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 GlobeNewswire - Wed Nov 6, 3:45PM CST

OCX : 2.65 (-3.53%)
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles GlobeNewswire - Wed Oct 16, 3:15PM CDT

OCX : 2.65 (-3.53%)
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial GlobeNewswire - Tue Oct 8, 7:30AM CDT

OCX : 2.65 (-3.53%)
OncoCyte: Q2 Earnings Snapshot AP - Thu Aug 8, 3:40PM CDT

OncoCyte: Q2 Earnings Snapshot

OCX : 2.65 (-3.53%)
Wall Street - NYSE Full View
S&P Futures Tick Lower as Investors Digest Big Bank Earnings Barchart - Fri Apr 12, 4:32AM CDT

June S&P 500 E-Mini futures (ESM24) are down -0.12% this morning as market participants geared up for earnings from big U.S. banks.

ESM24 : 5,471.89s (-0.09%)
JPM : 244.76 (+1.65%)
WFC : 74.83 (+1.70%)
C : 68.95 (+0.98%)
PARA : 11.09 (+4.82%)
AAPL : 228.52 (-0.21%)
TEAM : 253.97 (+3.47%)
FAST : 82.36 (+0.66%)
VAR1.D.DX : 2.064 (-7.57%)
AMD : 137.49 (-0.08%)
INTC : 24.44 (+1.79%)
OCX : 2.65 (-3.53%)
Oncocyte Corporation to Present at the LD Micro Invitational XIII Newsfile - Thu Jun 1, 2023

Irvine, California--(Newsfile Corp. - June 1, 2023) - Oncocyte Corporation (NASDAQ: OCX) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard...

OCX : 2.65 (-3.53%)
Oncocyte to Participate at Upcoming Investor Conferences Globe Newswire - Wed Aug 3, 2022

IRVINE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient...

OCX : 2.65 (-3.53%)
Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022 Globe Newswire - Mon Aug 1, 2022

IRVINE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient...

OCX : 2.65 (-3.53%)

Barchart Exclusives

Up 99% in the Past Year, How High Can This Growth Stock Rise? Barchart - 18 minutes ago
With Lumentum shares skyrocketing over the past year, can this growth stock keep climbing? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot